Compounds > 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone
Page last updated: 2024-08-24

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Mucositis, Oral

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Mucositis, Oral in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bedikian, AY; Bodey, GP; Burgess, MA; Freireich, EJ1

Other Studies

1 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Mucositis, Oral

ArticleYear
Phase I study of aziridinylbenzoquinone (NSC 182986).
    Cancer clinical trials, 1981,Winter, Volume: 4, Issue:4

    Topics: Adult; Aged; Anemia; Aziridines; Azirines; Benzoquinones; Bone Marrow; Cyclohexenes; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Stomatitis; Thrombocytopenia; Vomiting

1981